Atlas Trials

An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes

Clinical trial NCT00577148 · TERMINATED

Trial details

NCT number
NCT00577148
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Fatty Liver
Start date
2008-02-01
Primary completion
2009-02-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.